Fabio Conti

3.4k total citations · 1 hit paper
98 papers, 1.9k citations indexed

About

Fabio Conti is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Fabio Conti has authored 98 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Epidemiology, 60 papers in Hepatology and 16 papers in Surgery. Recurrent topics in Fabio Conti's work include Liver Disease Diagnosis and Treatment (48 papers), Hepatitis C virus research (37 papers) and Hepatitis B Virus Studies (17 papers). Fabio Conti is often cited by papers focused on Liver Disease Diagnosis and Treatment (48 papers), Hepatitis C virus research (37 papers) and Hepatitis B Virus Studies (17 papers). Fabio Conti collaborates with scholars based in Italy, France and United States. Fabio Conti's co-authors include Pietro Andreoné, Francesco Giuseppe Foschi, S. Brillanti, G. Mazzella, F. Buonfiglioli, Gabriella Verucchi, Luigi Bolondi, Marco Lenzi, Paolo Caraceni and Alessandra Scuteri and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and European Heart Journal.

In The Last Decade

Fabio Conti

91 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals

2016 653 citations Fabio Conti, F. Buonfiglioli et al. Journal of Hepatology profile →

Peers

Countries citing papers authored by Fabio Conti

Since Specialization

Citations

This map shows the geographic impact of Fabio Conti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabio Conti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabio Conti more than expected).

Fields of papers citing papers by Fabio Conti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabio Conti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabio Conti. The network helps show where Fabio Conti may publish in the future.

Co-authorship network of co-authors of Fabio Conti

This figure shows the co-authorship network connecting the top 25 collaborators of Fabio Conti. A scholar is included among the top collaborators of Fabio Conti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabio Conti. Fabio Conti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Understanding Orthorexia Nervosa: A Systematic Review of Meta-analytical Findings 2025 ·Current Nutrition Reports ·Lorenzo Moccia, (unknown), (unknown), Delfina Janiri, Caterina Policola, Marco Cintoni, (unknown), Georgios D. Kotzalidis, Fabio Conti, Adolfo Bandettini di Poggio, Giovanni Camardese, Gabriele Sani	0
2	Comparative Analysis of Subclassification Systems in Patients with Intermediate-Stage Hepatocellular Carcinoma (Barcelona Clinic Liver Classification B) Receiving Systemic Therapy 2024 ·Current Oncology ·Luca Ielasi, Bernardo Stefanini, Fabio Conti, (unknown), Raffaella Tortora, Giulia Magini, Rodolfo Sacco, Tiziana Pressiani, Franco Trevisani, Francesco Giuseppe Foschi, Fabio Piscaglia, Alessandro Granito, Francesco Tovoli	2
3	Bridging trauma and eating disorders: the role of loneliness 2024 ·Frontiers in Psychiatry ·Paolo Meneguzzo, (unknown), Barbara Mezzani, Fabio Conti, Luca Maggi, Patrizia Todisco	5
4	Connections between eating psychopathology, loneliness, and quality of life: insights from a multi-center study 2024 ·Frontiers in Psychiatry ·Patrizia Todisco, (unknown), (unknown), Barbara Mezzani, Fabio Conti, Luca Maggi, Paolo Meneguzzo	1
5	Role of circulating microRNAs to predict hepatocellular carcinoma recurrence in patients treated with radiofrequency ablation or surgery 2021 ·HPB ·Matteo Canale, Francesco Giuseppe Foschi, Pietro Andreoné, Giorgio Ercolani, Giorgia Marisi, Fabio Conti, Ranka Vukotic, (unknown), Valentina Burgio, Francesca Ratti, Luca Aldrighetti, Francesco De Cobelli, Stefano Cascinu, Paola Ulivi, Andrea Casadei‐Gardini	8
6	1H-NMR Based Serum Metabolomics Highlights Different Specific Biomarkers between Early and Advanced Hepatocellular Carcinoma Stages 2020 ·Cancers ·Andrea Casadei‐Gardini, Laura Del Coco, Giorgia Marisi, Fabio Conti, Giulia Rovesti, Paola Ulivi, Matteo Canale, Giovanni Luca Frassineti, Francesco Giuseppe Foschi, Serena Longo, Francesco Paolo Fanizzi, Anna Maria Giudetti	43
7	Liver transplantation in Italy in the era of COVID 19: reorganizing critical care of recipients 2020 ·Internal and Emergency Medicine ·Antonio Daniele Pinna, Giovanni Vitale, Maria Cristina Morelli, Matteo Ravaioli, Cristiana Laici, (unknown), Massimo Del Gaudio, Fabio Conti, Luca Vizioli, Matteo Cescon	4
8	Profile of lenvatinib in the treatment of hepatocellular carcinoma: design, development, potential place in therapy and network meta-analysis of hepatitis B and hepatitis C in all Phase III trials 2019 ·SHILAP Revista de lepidopterología ·(unknown), Marco Puzzoni, Francesca Montagnani, Giorgia Marisi, (unknown), Alessandro Cucchetti, Leonardo Solaini, (unknown), Fabio Conti, Giorgio Ercolani, Stefano Cascinu, Mario Scartozzi	1
9	Risk factors for a difficult intravenous access: A multicentre study comparing nurses' beliefs to evidence 2019 ·Journal of Clinical Nursing ·Michela Piredda, Jacopo Fiorini, Gabriella Facchinetti, Valentina Biagioli, Anna Marchetti, Fabio Conti, Laura Iacorossi, Diana Giannarelli, Maria Matarese, Maria Grazia De Marinis	11
10	Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals 2018 ·Digestive and Liver Disease ·Andrea Casadei‐Gardini, Francesco Giuseppe Foschi, Fabio Conti, Elisabetta Petracci, Ranka Vukotic, Giorgia Marisi, F. Buonfiglioli, Giovanni Vitale, Federico Ravaioli, Stefano Gitto, Gabriella Verucchi, Marco Lenzi, Luigi Bolondi, G. Mazzella, S. Brillanti, Pietro Andreoné	47
11	Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals 2018 ·Digestive and Liver Disease ·Federico Ravaioli, Fabio Conti, S. Brillanti, Pietro Andreoné, G. Mazzella, F. Buonfiglioli, Ilaria Serio, (unknown), Maria Letizia Bacchi Reggiani, Agostino Colli, Giovanni Marasco, Antonio Colecchia, Davide Festi	52
12	Imaging features of microvascular invasion in hepatocellular carcinoma developed after direct-acting antiviral therapy in HCV-related cirrhosis 2017 ·European Radiology ·Matteo Renzulli, F. Buonfiglioli, Fabio Conti, Stefano Brocchi, Ilaria Serio, Francesco Giuseppe Foschi, Paolo Caraceni, G. Mazzella, Gabriella Verucchi, Rita Golfieri, Pietro Andreoné, S. Brillanti	62
13	Optimization of direct anti‐viral agent treatment schedule: Focus on HCV genotype 3 2017 ·United European Gastroenterology Journal ·Filomena Morisco, (unknown), Silvia Camera, A Ippolito, Michele Stanislaw Milella, Fabio Conti, Chiara Masetti, A. Smedile, Paolo Tundo, Teresa Santantonio, (unknown), (unknown), Pietro Gatti, Vincenzo Messina, A. Iacobellis, (unknown), Nicola Caporaso, Angelo Andriulli	4
14	Liver grafts from hepatitis B surface antigen-positive donors: A review of the literature 2016 ·World Journal of Gastroenterology ·Elisabetta Loggi, Fabio Conti, Alessandro Cucchetti, Giorgio Ercolani, Antonio Daniele Pinna, Pietro Andreoné	21
15	Chronic hepatitis B: Are we close to a cure? 2015 ·Digestive and Liver Disease ·Elisabetta Loggi, Giovanni Vitale, Fabio Conti, Mauro Bernardi, Pietro Andreoné	15
16	Trans-catheter mitral valve implantation for mitral regurgitation 2015 ·Journal of Cardiovascular Medicine ·Francesco Romeo, Valeria Cammalleri, Giovanni Ruvolo, (unknown), (unknown), Saverio Muscoli, (unknown), (unknown), Fabio Conti, Gian Paolo Ussia	9
17	Hypertension-Linked Mutation of α-Adducin Increases CFTR Surface Expression and Activity in HEK and Cultured Rat Distal Convoluted Tubule Cells 2012 ·PLoS ONE ·(unknown), (unknown), (unknown), Maria Lisa Garavaglia, Claudia Bazzini, Simona Rodighiero, Valeria Vezzoli, Fabio Conti, Lucia Torielli, Giovambattista Capasso, Markus Paulmichl, G. Meyer	9
18	Vitamins in the treatment of chronic viral hepatitis 2011 ·British Journal Of Nutrition ·Sirio Fiorino, Fabio Conti, Annagiulia Gramenzi, Elisabetta Loggi, Carmela Cursaro, Roberto Di Donato, L. Micco, Stefano Gitto, (unknown), Mauro Bernardi, Pietro Andreoné	8
19	603 A MULTICENTER ITALIAN CROSS-SECTIONAL STUDY IN ELDERLY PATIENTS WITH HEPATITIS C VIRUS (HCV) INFECTION 2009 ·Journal of Hepatology ·Fabio Conti, Mario Luca Morieri, Annagiulia Gramenzi, Calogero Cammà, Antonio Grieco, A. Picciotto, Gloria Taliani, (unknown), (unknown), (unknown), F. Ancarani, M. Chiaramonte, Gabriella Verucchi, Antonio Craxı̀, Mauro Bernardi, Pietro Andreoné	1
20	Low density lipoprotein receptor transcripts correlates with liver hepatitis C virus RNA in patients with alcohol consumption 2006 ·Journal of Viral Hepatitis ·Matthieu Carrière, Arielle R. Rosenberg, Fabio Conti, Sandrine Chouzenoux, Benoît Terris, Philippe Sogni, Olivier Soubrane, Yvon Calmus, Philippe Podevin	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact